文献速递冠心病血脂与心血管预防

COVID-19疫情期间急性心肌梗死管理与结局的种族差异

Racial differences in management and outcomes of acute myocardial infarction during COVID-19 pandemic.
PubMed 文献 · Heart · 2021-03-08

研究基于英格兰多源国家医疗记录,纳入2020年2月1日至5月27日因急性心肌梗死住院患者为COVID-19组,前三年同期住院患者为前COVID-19组,比较黑人、亚裔及少数族裔(BAME)与白人的入院率、治疗和死亡率。结果显示COVID-19期间BAME患者AMI住院比例更高(16.7% vs 10.1%),非ST段抬高型AMI接受冠脉造影比例更低(86.1% vs 90.0%),再灌注延迟更长(4.1小时 vs 3.7小时),院内死亡(OR 1.68, 95%CI 1.27-2.28)和7天死亡(OR 1.81, 95%CI 1.31-2.19)风险较前COVID-19时期更高。

要点

  • COVID-19期间BAME患者AMI住院比例较前COVID-19时期更高(16.7% vs 10.1%)。
  • BAME患者非ST段抬高型AMI接受冠脉造影比例低于白人(86.1% vs 90.0%)。
  • BAME患者再灌注延迟更长(4.1小时 vs 3.7小时),早期死亡风险更高。

核心结论

  • COVID-19期间BAME患者AMI住院比例更高,接受指南推荐治疗更少,早期死亡率较前COVID-19时期更高。

研究设计与样本

  • 多源国家医疗记录链接的队列研究,纳入英格兰2020年1月1日至5月27日因AMI住院患者为COVID-19组,前三年同期住院患者为前COVID-19组,共73 746例。

主要发现

  • COVID-19期间BAME患者AMI住院比例16.7%,前COVID-19时期为10.1%。
  • COVID-19期间BAME患者非ST段抬高型AMI接受冠脉造影比例86.1%,白人为90.0%(p<0.001)。
  • BAME患者再灌注中位延迟4.1小时,白人为3.7小时(p<0.001)。
  • BAME患者院内死亡OR 1.68(95%CI 1.27-2.28),7天死亡OR 1.81(95%CI 1.31-2.19),均较前COVID-19时期升高。

临床怎么用

  • 应关注COVID-19期间BAME患者AMI的诊疗公平性,优化临床路径以确保及时再灌注和指南推荐治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: There are concerns that healthcare and outcomes of black, Asian and minority ethnic (BAME) communities are disproportionately impacted by the COVID-19 pandemic. We investigated admission rates, treatment and mortality of BAME with acute myocardial infarction (AMI) during COVID-19. METHODS: Using multisource national healthcare records, patients hospitalised with AMI in England during 1 February-27 May 2020 were included in the COVID-19 group, whereas patients admitted during the same period in the previous three consecutive years were included in a pre-COVID-19 group. Multilevel hierarchical regression analyses were used to quantify the changes in-hospital and 7-day mortality in BAME compared with whites. RESULTS: Of 73 746 patients, higher proportions of BAME patients (16.7% vs 10.1%) were hospitalised with AMI during the COVID-19 period compared with pre-COVID-19. BAME patients admitted during the COVID-19 period were younger, male and likely to present with ST-elevation acute myocardial infarction. COVID-19 BAME group admitted with non-ST-elevation acute myocardial infarction less frequently received coronary angiography (86.1% vs 90.0%, p<0.001) and had a longer median delay to reperfusion (4.1 hours vs 3.7 hours, p<0.001) compared with whites. BAME had higher in-hospital (OR 1.68, 95% CI 1.27 to 2.28) and 7-day mortality (OR 1.81 95% CI 1.31 to 2.19) during COVID-19 compared with pre-COVID-19 period. CONCLUSION: In this multisource linked cohort study, compared with whites, BAME patients had proportionally higher hospitalisation rates with AMI, less frequently received guidelines indicated care and had higher early mortality during COVID-19 period compared with pre-COVID-19 period. There is a need to develop clinical pathways to achieve equity in the management of these vulnerable populations.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Rashid M, Timmis A, Kinnaird T, et al. Racial differences in management and outcomes of acute myocardial infarction during COVID-19 pandemic. Heart. 2021. PMID: 33685933. doi:10.1136/heartjnl-2020-318356

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。